Document Detail


p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
MedLine Citation:
PMID:  1974694     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The binding properties of p-[125I]iodoclonidine [( 125I]PIC) to human platelet membranes and the functional characteristics of PIC are reported. [125I]PIC bound rapidly and reversibly to platelet membranes, with a first-order association rate constant (kon) at room temperature of 8.0 +/- 2.7 x 10(6) M-1 sec-1 and a dissociation rate constant (koff) of 2.0 +/- 0.8 x 10(-3) sec-1. Scatchard plots of specific [125I]PIC binding (0.1-5 nM) were linear, with a Kd of 1.2 +/- 0.1 nM. [125I]PIC bound to the same number of high affinity sites as the alpha 2-adrenergic receptor (alpha 2-AR) full agonist [3H] bromoxidine (UK14,304), which represented approximately 40% of the sites bound by the antagonist [3H]yohimbine. Guanosine 5'-(beta, gamma-imido)triphosphate greatly reduced the amount of [125I]PIC bound (greater than 80%), without changing the Kd of the residual binding. In competition experiments, the alpha 2-AR-selective ligands yohimbine, bromoxidine, oxymetazoline, clonidine, p-aminoclonidine, (-)-epinephrine, and idazoxan all had Ki values in the low nanomolar range, whereas prazosin, propranolol, and serotonin yielded Ki values in the micromolar range. Epinephrine competition for [125I]PIC binding was stereoselective. Competition for [3H]bromoxidine binding by PIC gave a Ki of 1.0 nM (nH = 1.0), whereas competition for [3H]yohimbine could be resolved into high and low affinity components, with Ki values of 3.7 and 84 nM, respectively. PIC had minimal agonist activity in inhibiting adenylate cyclase in platelet membranes, but it potentiated platelet aggregation induced by ADP with an EC50 of 1.5 microM. PIC also inhibited epinephrine-induced aggregation, with an IC50 of 5.1 microM. Thus, PIC behaves as a partial agonist in a human platelet aggregation assay. [125I]PIC binds to the alpha 2B-AR in NG-10815 cell membranes with a Kd of 0.5 +/- 0.1 nM. [125I]PIC should prove useful in binding assays involving tissues with a low receptor density or in small tissue samples and in studies of cloned and expressed alpha 2-AR.
Authors:
M A Gerhardt; S M Wade; R R Neubig
Related Documents :
24400144 - Effect of decompression-induced bubble formation on highly trained divers microvascular...
6180924 - Modifications in the regression of the acute inflammation caused by a beta-adrenergic e...
23143634 - Mean platelet volume in neonatal sepsis.
23360844 - Mean platelet volume and its relation with arterial stiffness in patients with normoten...
9251244 - Synthesis of a new phosphoglycolipid with biological activity towards platelets.
11886574 - Neonatal alloimmune thrombocytopenia.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Molecular pharmacology     Volume:  38     ISSN:  0026-895X     ISO Abbreviation:  Mol. Pharmacol.     Publication Date:  1990 Aug 
Date Detail:
Created Date:  1990-09-20     Completed Date:  1990-09-20     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0035623     Medline TA:  Mol Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  214-21     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, University of Michigan Medical School, Ann Arbor 48109-0626.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenylate Cyclase / metabolism
Adrenergic alpha-Agonists / pharmacokinetics*
Blood Platelets / metabolism*
Cell Membrane / metabolism
Chromatography, Thin Layer
Clonidine / analogs & derivatives*,  pharmacokinetics
GTP-Binding Proteins / metabolism
Humans
Iodine Radioisotopes
Kinetics
Platelet Aggregation / drug effects
Radioligand Assay
Receptors, Adrenergic, alpha / metabolism*
Yohimbine / pharmacokinetics
Grant Support
ID/Acronym/Agency:
GM39561/GM/NIGMS NIH HHS; GM97863/GM/NIGMS NIH HHS; HL37551/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Agonists; 0/Iodine Radioisotopes; 0/Receptors, Adrenergic, alpha; 108294-53-7/4-iodoclonidine; 146-48-5/Yohimbine; 4205-90-7/Clonidine; EC 3.6.1.-/GTP-Binding Proteins; EC 4.6.1.1/Adenylate Cyclase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The analysis of population survey data on DNA sequence variation.
Next Document:  Generation of chromosome size polymorphism during in vivo mitotic multiplication of Plasmodium bergh...